The mutated frequency of BAP1 was also reported to be as high as 20% in ccRCC (15, 16), with RCC accounting for 9% of BAP1 tumor predisposition syndrome (BAP1-TPDS) (17). This evidence concerns the gene BAP1 and renal cell carcinoma.